agebuzz gives you the latest news, info and opinion on all aspects of aging…
when it comes to aging, we read everything so you don’t have to…

By Carolyn Brandly New drugs for the treatment of people with mild cognitive impairments and early-stage Alzheimer’s disease are grabbing headlines and attracting worldwide attention. While the treatments may hold promise for some people, practical actions hold promise for many more people to prevent or delay dementia. Prevention…
Read More
Carolyn Brandly is a PhD Candidate at the University of Victoria, Canada, with 20+ years of experience working with older adults and people living with dementia. She is also the Editor of Dementia Connections, a newsletter that shares inspiring stories, expert advice, and the latest developments in dementia care and research. Sign up for free at dementiaconnections.org.



| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |

Sign up for agebuzz’s free weekly newsletter sent every Thursday